Medications

US panel sees risk in long-used osteoporosis drug

A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

Diseases, Conditions, Syndromes

New technique opens the door to development of osteoperosis drugs

Scientists from the University of Granada (UGR) have opened the door to the development of new drugs against osteoporosis, one of the most common chronic illnesses in the world, especially among women 65 or over.

page 5 from 6